Among these dysregulated RNAs, NKILA was found significantly downregulated in NPC, the decline of NKILA was more pronounced in patients with distant metastases, consistent with previously reported in breast cancer, Hepatocellular carcinoma and laryngeal cancer [21, 25, 31–33]. This evidence concerns the gene NKILA and hepatocellular carcinoma.